Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

Archive for July, 2010

Endo a lot more than just Percocet

Tuesday, July 20th, 2010

Executives at Chadds Ford, Pa.-based Endo Pharmaceuticals have had a busy few weeks. CEO Dave Holveck and Dr. Ivan Gergel, executive VP, research and development, were among the Endo executives who got to ring the opening bell of the Nasdaq on Monday to mark the company's 10th anniversary trading on ...

Mental illness R&D reaches record level

Tuesday, July 20th, 2010

Offering further proof of the lucrative appeal of mental health drugs despite the continuing minefield for researchers, there are a record 313 new drugs in development to treat conditions ranging from Alzheimer’s disease and depression to schizophrenia and addictive disorders, according to a new report by the Pharmaceutical Researchers and ...

   
©2012 UBM Canon